A Randomized, Double-blind, Placebo-controlled Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JX2105 in Healthy Chinese Subjects Trial Phase 1 Enrolling by invitation Aug. 4, 2024
Attentional Focus and Prefrontal Cortical Activation in Older Adults and Patients With Parkinson's Disease (PD) Trial N/A Completed Aug. 1, 2024
Choice of Anesthesia in Microelectrode Recording Guided Deep Brain Stimulation for Parkinson's Disease Trial N/A Recruiting July 31, 2024
Noninterventional Study Evaluating Parkinson's Disease Diary Use Trial N/A Active, not recruiting July 30, 2024
Developing Personalized Medicine Strategies to Increase Physical Activity in Parkinson's Disease (PD) Through Digital Health Technology Trial N/A Completed July 28, 2024
Effortful Swallow Maneuver for Swallowing Impairment in People With Parkinson Disease Trial N/A Completed July 28, 2024
Long Term Follow-up of Patients With Parkinson's Disease Who Had Administered of A9-DPC in SB-PD-001 Study Trial N/A Active, not recruiting July 25, 2024
Phase IIa Randomized Placebo Controlled Trial: Mesenchymal Stem Cells as a Disease-modifying Therapy for Idiopathic Parkinson's Disease Trial Phase 2 Completed July 25, 2024
The Effect of Upper Extremity Telerehabilitation on Balance and Gait Trial N/A Completed July 25, 2024
A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease Trial Phase 2 Completed July 22, 2024
Exploring Sarcopenia in Parkinson's Disease Patients by Combining Serum Biomarker Levels Trial N/A Not yet recruiting July 21, 2024